ArticleProceedings of the National Academy of Sciences of the United States of America2012

Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells.

Ding Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.